February 2, 2012
SKOKIE, IL -- NanoProfessor(R), a division of NanoInk(R), Inc. focused on nanotechnology education, announced today a partnership with City Colleges of Chicago in which two City Colleges students will complete a specially designed "Introduction to Nanotechnology" course followed by a paid summer internship program working in the Skokie-based NanoProfessor labs. It marks the first step [...]
February 2, 2012
LA JOLLA, Calif. and CORALVILLE, Iowa - Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and Integrated DNA Technologies, Inc. (IDT), the world leader in production and supply of oligonucleotides, today jointly announced that they have entered into an agreement to manufacture, market, [...]
New Handheld Narcotics Analyzer Gives Edge to Law Enforcement in War on Drugs
February 2, 2012
WALTHAM, Mass.- Thermo Fisher Scientific Inc., the world leader in serving science, today introduced Thermo Scientific TruNarc, a new handheld narcotics analyzer that gives local law enforcement a significant technology edge in the war on drugs. TruNarc® can replace more subjective presumptive field tests (color tests) used by law enforcement for decades. The core technology [...]
February 2, 2012
SAN DIEGO, Sequenom, Inc. today announced that a new publication of an independent multi-center study on Sequenom Center for Molecular Medicine's MaterniT21™ laboratory-developed test (LDT) appears today in the online issue of Genetics in Medicine. The study demonstrated the LDT can detect fetal trisomy 21, 18 and 13 with high accuracy from a maternal blood [...]
PerkinElmer Announces Financial Results for the Fourth Quarter of 2011
February 2, 2012
WALTHAM, Mass. - PerkinElmer, Inc. PKI -0.57% , a global leader focused on improving the health and safety of people and the environment, today reported financial results for the fourth quarter ended January 1, 2012. The Company reported a GAAP loss per share from continuing operations of $0.75, as compared to earnings per share of [...]
SPRIworks HT from Beckman Coulter Automates Sample Preparation for Next Generation Sequencing,
February 2, 2012
BREA, CALIF.- Beckman Coulter Life Sciences will launch SPRIworks HT*, a high-throughput solution for fragment library preparation on Illumina next generation sequencers, at SLAS2012, which convenes Feb. 4-8 in San Diego. The system, which will be displayed at the conference in booth 619, allows researchers to process libraries with greater speed and sample reproducibility and [...]
Integromics partners with FPGMX to develop low-cost methods for clinical genomics
February 2, 2012
Granada and Madrid, Spain and Philadelphia, PA, U.S., Integromics®, a market leader in IT solutions provision for life sciences in the field of genomics and proteomics, today announces it has entered into a partnership with Professor Carracedo and his team at the Galician Foundation of Genomic Medicine (FPGMX), a recipient of the European Life Technologies [...]
Precision BioSciences Announces Allowance of Fourth U.S. Patent Related to Engineered Meganucleases
February 2, 2012
RESEARCH TRIANGLE PARK, N.C.- Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/246,380 (“the '380 Application”). The allowed claims relate to an array of genome engineering methods, including the use of [...]
February 2, 2012
AUSTIN, Texas - Asuragen, Inc. announced today it has been appointed a Certified Service Provider (CSP) by Life Technologies (NASDAQ: LIFE) for Ion Torrent’s Personal Genome Machine (PGM). The Ion Torrent CSP Program is designed to assure customers that Asuragen has been trained and tested by Ion Torrent in the use of its semiconductor sequencing [...]
February 2, 2012
LEXINGTON, Mass., T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled "NMR Device for Detection of Analytes". The patent broadly covers devices and methods of detecting analytes through magnetic resonance measurement, the basis for T2 Bio's [...]
